Brooklyn Investment Group’s Avidity Biosciences RNAM Stock Holding History

Brooklyn Investment Group’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,722	Closed	-$990K	–	1994
2025 Q4	$990K	Buy	+13,722	New	+$886K	0.05%	357
2025 Q3	–	Sell	-46	Closed	-$1.31K	–	2244
2025 Q2	$1.31K	Sell	46 -222	-83%	-$6.62K	﹤0.01%	2867
2025 Q1	$7.91K	Buy	+268	New	+$8.35K	﹤0.01%	1623

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Brooklyn Investment Group's RNAM Position: Q1 2026 in Review

Brooklyn Investment Group sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 13,722 shares — an estimated $990K sold.

Brooklyn Investment Group first reported a position in RNAM in Q1 2025 and held it in 3 quarters. The position peaked at $990K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Brooklyn Investment Group reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Brooklyn Investment Group sold 13,722 Avidity Biosciences shares in Q1 2026, an estimated $990K.
Brooklyn Investment Group first reported a position in Avidity Biosciences in Q1 2025 and held it in 3 quarters.
Brooklyn Investment Group's Avidity Biosciences position peaked at $990K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.